Sign in
4

Changes in Ownership

Altimmune, Inc. Filed Acc 0001802615-26-000002

Chief Medical Officer gave up 12,679 shares (to pay taxes)

  • Chief Medical Officer acquired 37,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Arbet-Engels Christophe Chief Medical Officer 2026-10-01 Option exercise +37,500 37,500 D: show line 1 in the form
Arbet-Engels Christophe Chief Medical Officer 2026-10-01 Shares withheld for taxes −12,679 $2.76 $34,994 24,821 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Arbet-Engels Christophe Chief Medical Officer 2026-10-01 Option exercise · Restricted Stock Units −37,500 112,500 D: show line 3 in the form
Loading xslF345X06/form4-10052026_041009.xml…